Jennifer Jackman
Twenty-Five Years of Mifepristone: How Activists Brought the Abortion Pill to America and Changed Reproductive Health Forever
At the urging of antiabortion advocates and politicians, and based on a flawed and biased report put out by an antiabortion group, the Trump administration announced the launch of a new review of mifepristone—despite 100 peer-reviewed scientific studies proving the safety and efficacy of these medications and safe use by over 7.5 million U.S. women.
On the 25th anniversary of FDA approval of mifepristone, reproductive rights supporters are celebrating the creative, determined and courageous advocates who brought this medication to market.
One organization that played a critical role in bringing mifepristone, known as RU-486, to the United States was the Feminist Majority Foundation (FMF)—today the publisher of Ms.
-
A Message From the Life of Urvashi Vaid: Do Not Remain Silent
-
Leading Health Groups Slam Trump and RFK’s Claims Linking Tylenol to Autism: ‘Irresponsible and Misleading’
-
The Return of the Tradwife Gospel
-
Texas’ Newest Abortion Restriction Tells Us What We Already Knew: It Was Never About States’ Rights
Get the Ms. Weekly News Digest:
Listen, Rate, Review and subscribe on:
Fifteen Minutes of Feminism: What's In The Epstein Files? Republicans and Democrats Want to Know (with George Conway)
In this episode, at a time where unprecedented news stories break every day, we’re re-elevating the Jeffrey Epstein files. As victims continue to come forward, and new evidence continues to emerge, the questions and demands for justice grow louder. What can we learn from the information that has been released? What will it take for the full files to be released? And how will Trump respond?
-
Get the magazine and join the community
Become a Member -
Support Ms.
Donate
Feminist Daily Newswire
Feminist Majority Foundation
- Taliban’s 5-Year Strategic Plan Excludes Women. Afghan Women Push Back.
- The Afghan People Want Education for Their Girls. The Taliban Says No.
- Texas A&M Professor’s Firing Sparks Debate Over Academic Freedom
- Taliban Bans WiFi in Afghanistan, Cutting Off a Lifeline for Women and Students
- SCOTUS Greenlights Racial Profiling in Immigration Enforcement
From the Magazine:
Get Ms.’s award-winning feminist reporting delivered directly to your mailbox!
-
In Upcoming Virginia, N.J. and Pennsylvania Elections, Women’s Votes Will Decide the Future of Reproductive Rights and Equality
All eyes will be on the elections this fall in Virginia, New Jersey, Pennsylvania and beyond. These contests are not just bellwethers for next year’s midterms—they’re critical tests of how far Americans will go to defend women’s rights and equality at the state and national levels.
Women’s votes will be decisive. Pollster Celinda Lake told Ms. that women “are our own voters, we make up our own minds.” That independence has shaped elections for decades, with women consistently leaning more Democratic than men. This fall—from Virginia’s history-making two-woman governor’s race, to Pennsylvania’s Supreme Court retention battles—reproductive rights and equality are squarely on the ballot.
The message is clear: State-level elections matter profoundly, especially for women. The Dobbs decision pushed abortion and gender equality battles back to the states, and now voters must decide who will stand up for their rights.
David Becker / Getty Images
The Part of the Epstein Story We Keep Ignoring? Survivors.
Virginia Giuffre fought Jeffrey Epstein and Ghislaine Maxwell for decades. As a survivor of their trafficking, she spoke truth to power and endured public scrutiny as she became one of their most vocal and transparent accusers. On April 24, she died by suicide.
Her death should have marked a devastating failure of our systems to support trafficking survivors. Instead, it became another footnote in a political circus focused on conspiracy theories and file releases.
